Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Roe

Showing results (101-110 of 468) with videos related to

Pageof 47
Sort By:
Clinical Cardiology|January 1, 2019
Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network RegistryMichael C Kontos, Christopher B Fordyce, Anita Y Chen, et al.
American Heart Journal|December 17, 2013
Trends in outcomes among older patients with non-ST-segment elevation myocardial infarctionChee Tang Chin, Tracy Y Wang, Anita Y Chen, et al.
The American Journal of Medicine|May 17, 2020
Elevated Uric Acid Prevalence and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from RELAXAnthony P Carnicelli, Jie-Lena Sun, Brooke Alhanti, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data RegistrySunil V Rao, Fang-Shu Ou, Tracy Y Wang, et al.
Journal of the American College of Cardiology|May 16, 2015
Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United StatesKrishna G Aragam, Dadi Dai, Megan L Neely, et al.
The American Journal of Cardiology|November 1, 2012
Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarctionRobert W Harrison, Atul Aggarwal, Fang-shu Ou, et al.
American Heart Journal|June 4, 2014
The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary interventionTracy Y Wang, David J Magid, Henry H Ting, et al.
The American Journal of Medicine|August 30, 2008
Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarctionTracy Y Wang, Anita Y Chen, Karen P Alexander, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 23, 2008
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromesUptal D Patel, Fang-Shu Ou, E Magnus Ohman, et al.
Circulation. Cardiovascular Quality and Outcomes|July 31, 2014
Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline programTarun W Dasari, Matthew T Roe, Anita Y Chen, et al.
Pageof 47

Showing results (101-110 of 468) with videos related to

Sort By:
Pageof 47
Clinical Cardiology|January 1, 2019
Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network RegistryMichael C Kontos, Christopher B Fordyce, Anita Y Chen, et al.
American Heart Journal|December 17, 2013
Trends in outcomes among older patients with non-ST-segment elevation myocardial infarctionChee Tang Chin, Tracy Y Wang, Anita Y Chen, et al.
The American Journal of Medicine|May 17, 2020
Elevated Uric Acid Prevalence and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from RELAXAnthony P Carnicelli, Jie-Lena Sun, Brooke Alhanti, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data RegistrySunil V Rao, Fang-Shu Ou, Tracy Y Wang, et al.
Journal of the American College of Cardiology|May 16, 2015
Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United StatesKrishna G Aragam, Dadi Dai, Megan L Neely, et al.
The American Journal of Cardiology|November 1, 2012
Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarctionRobert W Harrison, Atul Aggarwal, Fang-shu Ou, et al.
American Heart Journal|June 4, 2014
The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary interventionTracy Y Wang, David J Magid, Henry H Ting, et al.
The American Journal of Medicine|August 30, 2008
Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarctionTracy Y Wang, Anita Y Chen, Karen P Alexander, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 23, 2008
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromesUptal D Patel, Fang-Shu Ou, E Magnus Ohman, et al.
Circulation. Cardiovascular Quality and Outcomes|July 31, 2014
Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline programTarun W Dasari, Matthew T Roe, Anita Y Chen, et al.
Pageof 47